Leptin genotype and ß-adrenergic agonists
OwnerFoley Leigh Shaw Marquessinventor
Life of this patent
Estimating the term…
Abstract
A method of identifying livestock animal subgroups of the same species, from a group of livestock animals of the same species wherein the subgroup has similar genetic predispositions for response to Zilpaterol Hydrochloride (ZH) treatment with respect to marbling, HCW gain, REA size gain, DDMI, % EBF, and YG's. The genetic potential of each animal to respond to ZH treatment is established by determining the LeptinArg25Cys genotype and segregating individual animals into subgroups based upon the LeptinArg25Cys genotype.
Claims24
A method for identifying livestock animal subgroups of the same species, from a group of livestock animals of the same species comprising the subgroups, wherein the subgroup has similar genetic predispositions for response to Zilpaterol Hydrochloride treatment with respect to marbling, HCW gain, REA size gain, DDMI, % EBF, and YG's comprising:
- (a) determining genetic potential of each animal to respond to ZH treatment by determining the Leptin Arg25Cys genotype;
- and (b) segregating individual animals into subgroups based upon the Leptin Arg25Cys genotype.
A method of producing subgroups of animals based on their Leptin Arg25Cys genotype in order to optimize ZH treatment, whereby genotype subgroups either receive ZH treatment or either no ZH treatment or RH treatment;
- to capitalize on the known Leptin Arg25Cys genotype interactions with ZH treatment for the phenotypes of marbling score, stamped Quality Grades, REA size gain, HCW gain, DDMI (daily dry matter intake), and % EBF.
A method of selectively applying a combination of ZH, RH, and/or no β-AA based on an animals' leptin Arg25Cys genotype.
Dependencies are inferred from the claim text.